Funds investing in biotech and US smaller companies outpaced the rest of the market in June, FE fundinfo data shows, while gold portfolios and Seraphim Space Investment Trust sank to the bottom of the performance tables. Last month was a busy one for markets, with the US and Iran signing a peace agreement (which is largely holding), Keir Starmer resigning as the UK's prime minister and Elon Musk's SpaceX pulling off its massive float. Against that backdrop, June was a volatile month.